Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × Everolimus × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Carcinoma, Renal Cell 6 Neuroendocrine Tumors 5 Neoplasm Metastasis 4 Tuberous Sclerosis 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thymus Neoplasms 1 Skin Neoplasms 1 Seizures 1 Sarcoma 1 Recurrence 1 Pheochromocytoma 1 Phase IB 1 Paraganglioma 1 Ovarian Neoplasms 1 Nevus 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Lymphoma 1

Interventions

Specimen Handling 2 Sorafenib 2 Irinotecan 2 poly ICLC 1 pembrolizumab 1 durvalumab 1 dehydroftorafur 1 atezolizumab 1 Watchful Waiting 1 Vincristine 1 Platinum 1 Oxaliplatin 1 Observation 1 Nivolumab 1 Ipilimumab 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Doxorubicin 1 DT2216 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡